Endomimetics, Inc.
Birmingham, AL Endomimetics, LLC
- UEI
- Q1CBADXNJSL5
- CAGE
- 5T6X0
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2000 9th Ave S, Birmingham, AL 35205, USA
- Website
- endomimetics.com
- Founded
- 2007
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Endomimetics, Inc.
Endomimetics LLC is a for-profit corporate entity registered in SAM.gov since November 2009, specializing in advanced biomedical research and innovative biotechnology solutions. The company focuses on developing cutting-edge in vitro models and biomedical technologies, with a particular emphasis on creating sophisticated cellular and nanomatrix-based platforms for drug testing and medical device improvements. Their research leverages sophisticated biotechnological approaches, including nanomatrix cell sheet technology, biocompatible peptide-based materials, and advanced imaging and testing methodologies to address complex medical challenges.
The company has received multiple federal grants from civilian agencies, primarily the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, focusing on developing advanced medical technologies. Their recent grant awards demonstrate expertise in creating innovative solutions for cardiovascular and orthopedic medical challenges, including developing automated 3D in vitro vascular sheets for atherosclerosis research, creating bionanomatrix coatings for knee joint implants to reduce infection and inflammation, and designing dual-action drug-coated balloons to mitigate neointimal hyperplasia and promote endothelialization. These projects are typically funded through Small Business Innovation Research (SBIR) programs, with grant awards ranging from $304,119 to support research projects aimed at revolutionizing medical testing, drug development, and implant technologies. Each project emphasizes developing alternative testing models that reduce reliance on animal studies while providing more precise and human-relevant research platforms.
Quick answers
What is Endomimetics, Inc.'s UEI?
Endomimetics, Inc.'s Unique Entity ID (UEI) in SAM.gov is Q1CBADXNJSL5.
What is Endomimetics, Inc.'s CAGE code?
Endomimetics, Inc.'s CAGE code is 5T6X0.
Where is Endomimetics, Inc. located?
Endomimetics, Inc.'s physical address in SAM.gov is 2000 9th Ave S, Birmingham, AL 35205, USA.
Is Endomimetics, Inc. registered in SAM.gov?
Yes. Endomimetics, Inc.'s SAM.gov registration is active through September 8, 2027.
What is Endomimetics, Inc.'s most recent federal award?
Endomimetics, Inc.'s most recent federal grant award is Atherosclerosis assay development for drug efficacy and cytotoxicity screening - project summary cardiovascular disease,… (R43HL176310), from National Heart Lung and Blood Institute, on September 17, 2024.
On GovTribe
See Endomimetics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors